Crossbow Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Crossbow Therapeutics's estimated annual revenue is currently $7.4M per year.
- Crossbow Therapeutics's estimated revenue per employee is $155,000
- Crossbow Therapeutics's total funding is $91M.
Employee Data
- Crossbow Therapeutics has 48 Employees.
- Crossbow Therapeutics grew their employee count by 26% last year.
Crossbow Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO, President | Reveal Email/Phone |
3 | Co-Founder, VP Corporate Development and Operations | Reveal Email/Phone |
4 | Co-founder, VP Corporate Development and Operations | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Chief Scientific Officer | Reveal Email/Phone |
7 | SVP, Regulatory Affairs & Development Operations | Reveal Email/Phone |
8 | VP | Reveal Email/Phone |
9 | SVP Biology | Reveal Email/Phone |
10 | VP Antibody Discovery, Protein Engineering, Process Development | Reveal Email/Phone |
Crossbow Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Crossbow Therapeutics?
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.
keywords:N/A
$91M
Total Funding
48
Number of Employees
$7.4M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.7M | 48 | -21% | $77.6M |
#2 | $7.4M | 48 | -20% | N/A |
#3 | $13.3M | 48 | -36% | N/A |
#4 | $7.4M | 48 | -2% | N/A |
#5 | $3.7M | 48 | 26% | N/A |